ACMG Practice Guideline: lack of evidence for MTHFR polymorphism testing. - Wikidata - wikimedia - TriplyDB

ACMG Practice Guideline: lack of evidence for MTHFR polymorphism testing.

ACMG Practice Guideline: lack of evidence for MTHFR polymorphism testing.

http://www.wikidata.org/entity/Q34320780

about

Utilization of genetic tests: analysis of gene-specific billing in Medicare claims data.Hypercoagulable states: an algorithmic approach to laboratory testing and update on monitoring of direct oral anticoagulants.Prioritizing genomic applications for action by level of evidence: a horizon-scanning method.Pre- and post-test genetic counseling for chromosomal and Mendelian disorders.The relationship between hyperhomocysteinemia and neurodegeneration.MTHFR: Addressing Genetic Counseling Dilemmas Using Evidence-Based Literature.Optimal utilization of thrombophilia testing.Collaborative Counseling Considerations for Pharmacogenomic Tests.Prevalence of common hereditary risk factors for thrombophilia in Somalia and identification of a novel Gln544Arg mutation in coagulation factor V.Identification of Delivery Models for the Provision of Predictive Genetic Testing in Europe: Protocol for a Multicentre Qualitative Study and a Systematic Review of the Literature.Genetic Risk Factors in Venous Thromboembolism.MTHFR A1298C and C677T Polymorphisms Are Associated with Increased Risk of Venous Thromboembolism: A Retrospective Chart Review Study.Impact of baseline clinical and laboratory features on the risk of thrombosis in children with acute lymphoblastic leukemia: A prospective evaluation.Application of Single-Nucleotide Polymorphism-Related Risk Estimates in Identification of Increased Genetic Susceptibility to Cardiovascular Diseases: A Literature Review.Genetic epidemiology of neural tube defects.An Algorithmic Approach to Management of Venous Thromboembolism.No evidence for association of MTHFR 677C>T and 1298A>C variants with placental DNA methylation.Pathology-supported genetic testing directed at shared disease pathways for optimized health in later life.Signaling pathway genes for blood pressure, folate and cholesterol levels among hypertensives: an epistasis analysis

P2860

Q31157018-4DC0DC13-41B1-4C47-981F-1F425C7D5475 Q33875897-2713C92F-5662-468E-88AC-7F3706732697 Q36398661-1DDE286B-71E4-41F9-A367-C822930CAA2B Q36784201-AED6A72A-B7B7-439E-A25A-5CCDF3EC4EFD Q38794990-5D51D6D1-BDE2-4FC6-96C9-DC9622064A9C Q38821457-672127D3-C55A-47D8-82FF-57918DE78283 Q39266304-A1E517EE-E777-4696-9636-34D3D024B495 Q39411218-536265E3-9F97-4256-B148-2ED7D5315671 Q40049106-0C192F98-ADD6-4F6F-82A5-E0BF47E90E6A Q40063183-B52CAC69-D4BE-4280-829E-AB9F105C464E Q40577579-4067644A-E5FE-4A0D-B8F3-5C9719632794 Q47357186-DB6C75D7-67CA-49D8-B657-2DC65518F099 Q48243992-FA8585CA-94A2-458E-B7D8-ADD27DD32F49 Q49464137-D59255E0-B5D1-4E3D-AEA7-9729215623A4 Q50071717-9EF9626A-EB3A-4E1E-BDF7-0A249F288A7B Q50632129-D0657155-CDD8-4699-A344-F7AA5BECC831 Q52689990-24ED178E-B817-4D96-87AE-71269A085DCB Q53681869-A43BA593-9436-40E2-B167-D83AFBBAA70F Q58669902-9E21E082-B52A-4100-B8C1-F43D93677106

P2860

ACMG Practice Guideline: lack of evidence for MTHFR polymorphism testing.

http://www.wikidata.org/entity/Q34320780

description

2013 nî lūn-bûn

@nan

2013 թուականի Յունուարին հրատարակուած գիտական յօդուած

@hyw

2013 թվականի հունվարին հրատարակված գիտական հոդված

@hy

2013年の論文

@ja

2013年学术文章

@wuu

2013年学术文章

@zh-cn

2013年学术文章

@zh-hans

2013年学术文章

@zh-my

2013年学术文章

@zh-sg

2013年學術文章

@yue

name

ACMG Practice Guideline: lack of evidence for MTHFR polymorphism testing.

@ast

ACMG Practice Guideline: lack of evidence for MTHFR polymorphism testing.

@en

ACMG Practice Guideline: lack of evidence for MTHFR polymorphism testing.

@nl

type

label

ACMG Practice Guideline: lack of evidence for MTHFR polymorphism testing.

@ast

ACMG Practice Guideline: lack of evidence for MTHFR polymorphism testing.

@en

ACMG Practice Guideline: lack of evidence for MTHFR polymorphism testing.

@nl

prefLabel

ACMG Practice Guideline: lack of evidence for MTHFR polymorphism testing.

@ast

ACMG Practice Guideline: lack of evidence for MTHFR polymorphism testing.

@en

ACMG Practice Guideline: lack of evidence for MTHFR polymorphism testing.

@nl

P1433

Q34320780-11DEBF21-2134-4CEC-8A6C-91602E0F57CD

P1476

Q34320780-F7876084-0F2F-41D0-A82A-0A401A257CFD

P2093

Q34320780-5BD6D632-9A19-4EDF-81C9-AC8B026A7A44

Q34320780-8D2A05D2-F34E-4FC0-B8FA-6AC7BF0FA5C4

Q34320780-B94AF11D-12CB-4280-AD8A-0BA93B1589A3

P2860

Q34320780-098BDD84-142F-48EF-AD95-7415B75D236A

Q34320780-0DCB94C3-56B9-469C-A826-19EF3F2C4256

Q34320780-0E0C37B6-DF30-40E1-9AB4-C33936A5475D

Q34320780-1D38E2AB-9727-4EB2-9CD3-FD180FCDBD07

Q34320780-1E6CAFE7-9484-4964-B92F-377D7A3FFB51

Q34320780-204810AC-5971-4FCC-861A-9053D1159426

Q34320780-216EE997-F69F-45BA-AE07-10C78F8F09BA

Q34320780-25A77545-737B-410D-AE4A-C7A66DB4FD09

Q34320780-290EE080-FFAD-4DC4-B978-0A5177E79B5C

Q34320780-38CE11B2-1ACF-4AB5-A07A-3EF6F209DD81

P2888

Q34320780-8FBDC8A2-A400-4F37-ADC1-D4CABE745ACD

P304

Q34320780-82CACEF9-C4FF-4942-94CE-E1E26D2FC358

P31

Q34320780-F26DA809-D8B0-4AA3-804B-A9C0F92D82F7

P356

Q34320780-A3F6D822-0901-4076-9B84-35A1229C4DD5

P407

Q34320780-0A50E419-478F-4134-8090-FFDD90A82F20

P433

Q34320780-567104E8-7332-4E3F-B173-57F35B2EAA3F

P478

Q34320780-BD01299D-7860-4E6E-BD20-B8BBA062452C

P577

Q34320780-49B6EB9E-4A49-42EE-8B5F-8775152FA170

P5875

Q34320780-AF49226D-3D88-422A-98C0-0A5A4E39B47E

P698

Q34320780-430E6BBF-C469-48C9-B149-14EE8C2DA436

P356

P1433

Genetics in Medicine

P1476

ACMG Practice Guideline: lack of evidence for MTHFR polymorphism testing.

@en

P2093

Cynthia J Curry

http://www.w3.org/2001/XMLSchema#string

Helga V Toriello

http://www.w3.org/2001/XMLSchema#string

Scott E Hickey

http://www.w3.org/2001/XMLSchema#string

P2860

A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase

Neural tube defects and folate: case far from closed

Prevention of neural tube defects: results of the Medical Research Council Vitamin Study. MRC Vitamin Study Research Group

Homocysteine lowering with folic acid and B vitamins in vascular disease

Homocysteine lowering and cardiovascular events after acute myocardial infarction

American College of Medical Genetics consensus statement on factor V Leiden mutation testing

Homocysteine and coronary heart disease: meta-analysis of MTHFR case-control studies, avoiding publication bias

Strong association of 677 C>T substitution in the MTHFR gene with male infertility--a study on an indian population and a meta-analysis

Reconciling the evidence on serum homocysteine and ischaemic heart disease: a meta-analysis

Prevention of the first occurrence of neural-tube defects by periconceptional vitamin supplementation

P2888

P304

153-156

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/GIM.2012.165

http://www.w3.org/2001/XMLSchema#string

P407

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

15

http://www.w3.org/2001/XMLSchema#string

P577

2013-01-03T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

234047631

http://www.w3.org/2001/XMLSchema#string

P698

23288205

http://www.w3.org/2001/XMLSchema#string